These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 18320691)

  • 21. [Protease inhibitor Kaletra (Lopinavir/Ritonavir): significance and role in antiretroviral therapy of HIV infection and AIDS].
    Galegov GA
    Antibiot Khimioter; 2007; 52(1-2):42-5. PubMed ID: 18461809
    [No Abstract]   [Full Text] [Related]  

  • 22. Kaletra OK'd by FDA.
    James JS
    Posit Living; 2000 Nov; 9(9):8, 13. PubMed ID: 12154764
    [No Abstract]   [Full Text] [Related]  

  • 23. Effect of lopinavir/ritonavir monotherapy on quality of life and self-reported symptoms among antiretroviral-naive patients: results of the MONARK trial.
    Spire B; Marcellin F; Cohen-Codar I; Flandre P; Boue F; Dellamonica P; Raffi F; Norton M; Van Philippe N; Delfraissy JF
    Antivir Ther; 2008; 13(4):591-9. PubMed ID: 18672538
    [TBL] [Abstract][Full Text] [Related]  

  • 24. FDA notifications. HIV-1 adult treatment guidelines are updated.
    AIDS Alert; 2006 Jun; 21(6):71. PubMed ID: 16795141
    [No Abstract]   [Full Text] [Related]  

  • 25. FDA notifications. Generic lopinavir/ritonavir approved by FDA.
    AIDS Alert; 2009 May; 24(5):59. PubMed ID: 19452652
    [No Abstract]   [Full Text] [Related]  

  • 26. [First-line monotherapy with boostered protease inhibitor. Effectively reduce viral load with only one drug?].
    Theobald T; Jäger H
    MMW Fortschr Med; 2005 Apr; 147 Spec No 1():28-9. PubMed ID: 16385867
    [No Abstract]   [Full Text] [Related]  

  • 27. Hepatitis coinfection and LPV/RTV.
    Carter M
    IAPAC Mon; 2004 Oct; 10(10):398. PubMed ID: 15801120
    [No Abstract]   [Full Text] [Related]  

  • 28. Top stories of 2004. Back to the future: lopinavir/ritonavir as "monotherapy".
    Sax PE
    AIDS Clin Care; 2005 Jan; 17(1):4. PubMed ID: 15717366
    [No Abstract]   [Full Text] [Related]  

  • 29. Ritonavir and lopinavir/ritonavir package inserts are updated.
    AIDS Alert; 2005 Dec; 20(12):143-4. PubMed ID: 16397944
    [No Abstract]   [Full Text] [Related]  

  • 30. HIV monotherapy with ritonavir-boosted protease inhibitors: a systematic review.
    Bierman WF; van Agtmael MA; Nijhuis M; Danner SA; Boucher CA
    AIDS; 2009 Jan; 23(3):279-91. PubMed ID: 19114854
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Two studies show Kaletra and Isentress similarly suppress HIV, yet have different side effects.
    Proj Inf Perspect; 2009 Mar; (48):6. PubMed ID: 19492458
    [No Abstract]   [Full Text] [Related]  

  • 32. Atazanavir: new indication. First-line treatment: fewer gastrointestinal disorders but more cases of jaundice and a risk of torsades de pointes.
    Prescrire Int; 2009 Jun; 18(101):104. PubMed ID: 19637415
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ugandan children receive lower-strength Aluvia.
    AIDS Patient Care STDS; 2008 Jan; 22(1):86-7. PubMed ID: 18453040
    [No Abstract]   [Full Text] [Related]  

  • 34. Fosamprenavir (GW433908)/ritonavir in HIV-infected patients: efficacy and safety results from the Spanish Expanded Access Program.
    Pérez-Elias MJ; Sánchez-Conde M; Soriano V; Mallolas J; Luque I; Rodríguez-Alcántara F;
    Enferm Infecc Microbiol Clin; 2009 Jan; 27(1):28-32. PubMed ID: 19218000
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-HIV agents. Lopinavir--results after one year.
    TreatmentUpdate; 2001; 12(8):1-2. PubMed ID: 12132436
    [No Abstract]   [Full Text] [Related]  

  • 36. [Lopinavir/ritonavir monotherapy in the treatment of HIV infection. Introduction].
    Pulido Ortega F; Arribas López JR
    Enferm Infecc Microbiol Clin; 2008 Dec; 26 Suppl 16():1. PubMed ID: 19572436
    [No Abstract]   [Full Text] [Related]  

  • 37. Anti-HIV agents. Kaletra and Meltrex update.
    TreatmentUpdate; 2005; 17(5):4-5. PubMed ID: 17225278
    [No Abstract]   [Full Text] [Related]  

  • 38. Acute meningoencephalitis in chronic HIV infection: clinical resolution with lopinavir-ritonavir-containing therapy.
    De Socio GV; Martinelli L; Zazzi M; Baldelli F
    Clin Infect Dis; 2008 Jun; 46(12):1938. PubMed ID: 18540815
    [No Abstract]   [Full Text] [Related]  

  • 39. Good response to lopinavir/ritonavir-containing antiretroviral regimens in antiretroviral-naive HIV-2-infected patients.
    Bénard A; Damond F; Campa P; Peytavin G; Descamps D; Lascoux-Combes C; Taieb A; Simon F; Autran B; Brun-Vézinet F; Chêne G; Matheron S;
    AIDS; 2009 Jun; 23(9):1171-3. PubMed ID: 19349850
    [TBL] [Abstract][Full Text] [Related]  

  • 40. LPV monotherapy: 72-week data.
    IAPAC Mon; 2006 Jan; 12(1):9. PubMed ID: 17252624
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.